TOKYO - Japan's health ministry on Friday approved the administration of Pfizer Inc.'s coronavirus vaccine to children aged between 5 and 11 as the nationwide case count continues to climb with the rapid spread of the Omicron variant.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
